Liver fatty acid-binding protein might be a predictive marker of clinical response to systemic treatment in psoriasis

por Baran, Anna, Kiluk, Paulina, Maciaszek, Magdalena, Świderska, Magdalena, Flisiak, Iwona
Publicado 2019

The Level of FGF 21 as a New Risk Factor for the Occurrence of Cardiometabolic Disorders amongst the Psoriatic Patients

por Kiluk, Paulina, Baran, Anna, Kaminski, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2019

Decreased levels of vaspin and its potential association with cardiometabolic risk in patients with psoriasis: preliminary results

por Kiluk, Paulina, Baran, Anna, Kaminski, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2021

Methotrexate Decreases the Level of PCSK9—A Novel Indicator of the Risk of Proatherogenic Lipid Profile in Psoriasis. The Preliminary Data

por Krahel, Julita Anna, Baran, Anna, Kamiński, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2020

Chronic hepatitis B virus infection is associated with decreased serum 25(OH)D concentration in non-cirrhotic patients

por Parfieniuk-Kowerda, Anna, Świderska, Magdalena, Rogalska, Magdalena, Maciaszek, Magdalena, Jaroszewicz, Jerzy, Flisiak, Robert
Publicado 2019

Galectin-3 as a Novel Multifaceted and Not Only Cardiovascular Biomarker in Patients with Psoriasis with Regard to Systemic Treatment—Preliminary Data

por Baran, Anna, Kiluk, Paulina, Nowowiejska, Julia, Kaminski, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2022

Potential Predictive Value of Serum Pentraxin 3 and Paraoxonase 1 for Cardiometabolic Disorders Development in Patients with Psoriasis—Preliminary Data

por Baran, Anna, Stepaniuk, Anna, Kiluk, Paulina, Kaminski, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2022

Circulating ANGPTL8 as a Potential Protector of Metabolic Complications in Patients with Psoriasis

por Baran, Anna, Krahel, Julita Anna, Nowowiejska, Julia, Kaminski, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2023

Higher Serum Selenoprotein P Level as a Novel Inductor of Metabolic Complications in Psoriasis

por Baran, Anna, Nowowiejska, Julia, Krahel, Julita Anna, Kaminski, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2020

Elevated circulating Krüppel-like factor 4 level as a novel independent marker of the proatherogenic risk in patients with psoriasis: a preliminary study

por Baran, Anna, Krahel, Julita A., Kaminski, Tomasz W., Krawiel, Magdalena, Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2020

Serum Cholesteryl Ester Transfer Protein (CETP) and Sortilin (SORT) in Patients with Psoriasis with Relation to Systemic Treatment

por Nowowiejska, Julia, Baran, Anna, Krahel, Julita A., Kamiński, Tomasz W., Maciaszek, Magdalena, Flisiak, Iwona
Publicado 2022

High prevalence of anti-HEV antibodies among patients with immunosuppression and hepatic disorders in eastern Poland

por Parfieniuk-Kowerda, Anna, Jaroszewicz, Jerzy, Łapiński, Tadeusz W., Łucejko, Mariusz, Maciaszek, Magdalena, Świderska, Magdalena, Grzeszczuk, Anna, Naumnik, Beata, Rowiński, Mirosław, Flisiak, Robert
Publicado 2018